More information coming soon. If you have immediate questions or concerns,please contact Rep. Waxman’s DC office at 202.225.3976.
Related Documents:
3.13.2009 - Press Releases Energy and Commerce Committee Announces Investigation into Bayer CropScience Explosion 12.15.2008 - Speeches and Statements Chairman Waxman Releases Report Criticizing President's Assertion of Executive Privilege 11.13.2008 - Speeches and Statements Chairman Waxman Holds Hearing on Hedge Funds and the Financial Market 11.6.2008 - Speeches and Statements Chairman Waxman Praises GAO Transition Efforts 10.30.2008 - Press Releases Chairman Waxman Releases GAO Report on Federal Oversight of Part D Drug Pricing More Documents...
Related Files:
CRS Report - Who Regulates Whom? An Overview of U.S. Financial Supervision CRS Report - Economic Stimulus: Issues and Policies CRS Report - Financial Regulatory Reform: Analysis of the Consumer Financial Protection Agency: H.R. 3126 CRS Report - General Oversight Provisions in the American Recovery and Reinvestment Act: Requirements and Related Issues CRS Report - Executive Compensation: SEC Regulations and Congressional Proposals CRS Report - The Cost of Government Finanical Interventions, Past and Present CRS Report - "Say on Pay" and Other Corporate Governance Reform Initiatives CRS Report - Water Quality Issues in the 110th Congress: Oversight and Implementation